Fosun attends "Choose France" Summit for a third time
/PRNewswire/ -- On 13 May 2024, Guo Guangchang, Chairman of Fosun International, attended the Choose France Summit hosted by the French government in Paris....
Source: prnewswire.com
📰 Tridem Pharma News
Tridem Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tridem Pharma. Real-time updates on events, politics, business and more.
Fosun attends "Choose France" Summit for a third time - Thailand Business News
HONG KONG, May 16, 2024 /PRNewswire/ -- On 13 May 2024, Guo Guangchang, Chairman of Fosun International, attended the Choose France Summit hosted by the
Source: thailand-business-news.com
Fosun Collaborates with Non-profit Organizations to Provide "Chinese Solutions" to Jointly Build a Malaria-free World
/PRNewswire/ -- A song spreads throughout the world from the Premier League fields; a seminar explores how civilian orgnanizations can carry out charitable...
Source: prnewswire.com
Fosun Pharma Develops Innovative Artemisinin-based Antimalarial Drugs Contributing to the Efforts for A Malaria-free World Through the Belt and Road Initiative
/PRNewswire/ -- On April 25, 2023, World Health Organization (WHO) gave as the theme for World Malaria Day 2023 Time to deliver zero malaria: invest, innovate,...
Source: prnewswire.com
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. : Stock Market News and Information | 2196| CNE100001M79
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. : News, information and stories for SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Hong Kong Stock Exchange: 2196 | Hong Kong Stock Exchange
Source: marketscreener.com
Fosun Pharma Announces 2022 Annual Results: Achieved Steady Growth with Revenue from Record High Innovative Products and Global Commercialization Capability Improvement
Performance Highlights: During the reporting period, the revenue was RMB 43.952 billion, with a year-on-year growth of 12.66%; the net profit after deducting extraordinary gain or loss attributable... | March 28, 2023
Source: marketscreener.com